Corrigendum: Non-coding RNAs: Emerging Regulators of Sorafenib Resistance in Hepatocellular Carcinoma.

hepatocellular carcinoma (HCC) long non-coding RNAs (lncRNAs) microRNAs (miRNAs) non-coding RNAs (ncRNAs) sorafenib resistance

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
Historique:
received: 08 02 2020
accepted: 17 02 2020
entrez: 21 3 2020
pubmed: 21 3 2020
medline: 21 3 2020
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fonc.2019.01156.].

Identifiants

pubmed: 32195187
doi: 10.3389/fonc.2020.00277
pmc: PMC7063857
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

277

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2020 Lai, Feng, Abudoureyimu, Zhi, Zhou, Wang, Chu, Chen and Wang.

Auteurs

Yongting Lai (Y)

Department of Medical Oncology, Nanjing School of Clinical Medicine, Jinling Hospital, Southern Medical University, Nanjing, China.

Bing Feng (B)

Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.

Mubalake Abudoureyimu (M)

Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.

Yingru Zhi (Y)

Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.

Hao Zhou (H)

Department of Medical Oncology, Jinling Hospital, Nanjing Medical University, Nanjing, China.

Ting Wang (T)

Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.

Xiaoyuan Chu (X)

Department of Medical Oncology, Nanjing School of Clinical Medicine, Jinling Hospital, Southern Medical University, Nanjing, China.
Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.

Ping Chen (P)

Department of Oncology, First People's Hospital of Yancheng, Fourth Affiliated Hospital of Nantong University, Yancheng, China.

Rui Wang (R)

Department of Medical Oncology, Nanjing School of Clinical Medicine, Jinling Hospital, Southern Medical University, Nanjing, China.
Department of Medical Oncology, School of Medicine, Jinling Hospital, Nanjing University, Nanjing, China.

Classifications MeSH